跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
mRNA therapeutic
首页
药物
mRNA therapeutic
mRNA therapeutic
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
THERAPEUTIC COMPOSITIONS AND METHODS INVOLVING MRNA TRANSFECTION
EP 2943226 B1
申请人: HERZBERG MARK C
优先权: 2013
CN
EP
US
WO
10 件公开
Application of mRNA for use as a therapeutic agent for tumorous diseases
US 8217016 B2
申请人: HOERR INGMAR
优先权: 2001
US
10 件公开
MRNA THERAPEUTIC COMPOSITIONS
US 20250121046 A1
申请人: NUTCRACKER THERAPEUTICS INC
优先权: 2022
CN
US
7 件公开
Modulation of pre-mRNA using splice modulating oligonucleotides as therapeutic agents in the treatment of disease
US 8680254 B2
申请人: LUTZ GORDON J
优先权: 2010
US
7 件公开
PARTICLE-MEDIATED DELIVERY OF BIOLOGICS
US 2019275071 A1
申请人: MAYO FOUND MEDICAL EDUCATION & RES
优先权: 2016
US
WO
6 件公开
METHOD OF TREATING LOWER URINARY TRACT SYMPTOMS
US 2024108693 A1
申请人: VERSAMEB AG
优先权: 2021
CN
EP
US
WO
5 件公开
COMBINATION CONTAINING AN MRNA VACCINE OR AN MRNA ENCODED THERAPEUTIC PROTEIN AND AN IMMUNE MODULATING MRNA FOR IMPROVED OR REDUCED IMMUNOGENICITY TO INCREASE EFFICACY
US 20260083837 A1
申请人: IMGEN T SRL
优先权: 2023
CN
EP
US
WO
5 件公开
TRANSLATABLE MOLECULES AND SYNTHESIS THEREOF
EP 3589290 A4
申请人: ARCTURUS THERAPEUTICS INC
优先权: 2017
EP
US
5 件公开
A MICROBIAL SYSTEM FOR PRODUCTION AND DELIVERY OF EUKARYOTE-TRANSLATABLE MRNA TO EUKARYA
EP 4087934 A4
申请人: SIVEC BIOTECHNOLOGIES LLC
优先权: 2020
CN
EP
US
WO
4 件公开
SPLICE-SWITCHING OLIGONUCLEOTIDES TARGETING IL-4RA
EP 4577655 A1
申请人: AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR
优先权: 2022
CN
EP
US
WO
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈